STOCK TITAN

Guardant Health to Participate in Upcoming June Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Guardant Health, a leader in precision oncology, will participate virtually in two upcoming investor conferences. The first is the William Blair 41st Annual Growth Stock Conference on June 1, featuring a fireside chat at 12:00 PM PT. The second is the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, also at 12:00 PM PT.

Interested investors can access live and archived webcasts of these events via the company’s website. Guardant Health is known for its innovative blood tests and data analytics aimed at improving cancer care and patient outcomes.

Positive
  • None.
Negative
  • None.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating virtually in the following investor conferences.

  • William Blair 41st Annual Growth Stock Conference
    Fireside Chat on Tuesday, June 1st at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time
  • Goldman Sachs 42nd Annual Global Healthcare Conference
    Fireside Chat on Tuesday, June 8th at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets, and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes, and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Revealtest for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening.

FAQ

When is Guardant Health participating in the William Blair Growth Stock Conference?

Guardant Health will participate in the William Blair 41st Annual Growth Stock Conference on June 1 at 12:00 PM Pacific Time.

What is the date of the Goldman Sachs Global Healthcare Conference?

The Goldman Sachs 42nd Annual Global Healthcare Conference will be held on June 8 at 12:00 PM Pacific Time.

How can I access the webcasts of Guardant Health's investor conferences?

You can access live and archived webcasts of Guardant Health's investor conferences through the 'Investors' section of their website.

What does Guardant Health specialize in?

Guardant Health specializes in precision oncology, providing proprietary blood tests and analytics to improve cancer care.

Guardant Health, Inc.

NASDAQ:GH

GH Rankings

GH Latest News

GH Stock Data

3.85B
117.89M
4.57%
105.68%
7.6%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
PALO ALTO